Results: After 24 weeks of therapy, mean reduction of HBV-DNA level, the percentage of patients with HBV-DNA lower than 5 log10 copies/ml and the percentage of patients with HBV-DNA level decrease of more than 2 log10 copies/ml in group B were significantly higher than those in group A (P < 0.05, respectively). At the end of 24, 48 and 96 weeks, the patients in group B had higher rates of undetectable serum HBV-DNA levels and ALT normalization than those in group A (46% vs 25%, 74% vs 54.2%, 88% vs 70.8%; 52% vs 31.3%, 66% vs 43.8%, 82% vs 62.5%; P < 0.05, respectively). HBeAg seroconversion rate was significant hihger in group B than those in group A (48% vs 27.1%, P < 0.05). There was no evidence of adverse effect in patients treated for up to 96 weeks.
Background: To investigate peripheral T-lymphocyte subpopulation profile and its correlation with HBV precore region 1896 mutation in chronic HBV-infected (CHI) individuals with normal liver function tests.
Methods: HBV precore region 1896 mutation and distribution of T-lymphocyte subpopulations in peripheral blood were measured in CHI individuals with normal liver function tests. HBV markers were detected with ELISA. Serum HBV DNA load was assessed with quantitative real-time polymerase chain reaction. The results of peripheral T-cell subsets were compared among groups based on HBV precore region 1896 mutation status, HBeAg, age, sex and the quantities of HBV DNA.
Results: CHI individuals with normal liver function tests had significantly decreased CD4+ cells and CD4+/CD8+ ratio, and increased CD8+ cells compared with unifected controls, all with P < 0.01. Comparing with HBV precore region nonmutation group, the patients with precore mutation had significant decreased CD4+ cells and CD4+/CD8+ ratio and increased CD8+ cells. Univariate analysis showed a similar pattern of these parameters was significantly associated with presence of serum HBeAg expression and high viral load, all with P < 0.05 or 0.01. The presence of HBeAg expression carried by the HBV precore region mutation positive group were not significant different than those observed in HBV precore region mutation negative group. There is a significant difference in the quantities of HBV DNA between the HBV precore region mutation positive group and negative group. No obvious differences of Tcell parameters and presence of precore mutation were observed among various age groups and sex groups, all with P > 0.05.
Conclusion: T-lymphocyte impaired balance was significantly associated with HBV precore region mutation in CHI individuals with normal liver function tests. Which with HBeAg expression and the HBV DNA replication affect each other and co-result in lower T-cell immune function and chronic infection persistent status. Methods: A stratified multistage cluster sampling technique with probability proportional to size was used to select around 6400 individuals aged between 5 and 19 years residents of the State capitals and the Federal District. The sample was stratified according to age (5-9 and 10-to 19-years-old) within each region. Individualand household-level data were collected by home inter-e238 14th International Congress on Infectious Diseases (ICID) Abstracts view. Total antibodies to hepatitis A virus were detected by EIA. Frequencies of HAV infection by region and the age distribution of the susceptible population were estimated and odds ratio (95% CI) were calculated using GLLAMM.
Results: The prevalence of hepatitis A infection in the 5-9 and 10-19 age-group by region: North (28.7% and 67.5%); Northeast (41.5% and 57.4%); Midwest (32.3 and 56.0%); Federal District (33.8% and 65.1%); Southeast (20.6% and 37.7%); South (18.9% and 34.5%). There was increasing trend for the prevalence of HAV infection with age in all sites. The curves of susceptible populations differed from one area to another. Multilevel modelling showed that deprivation/low socio-economic status was associated with HAV infection in all regions.
Conclusion: This is the first national population-based survey to determine prevalence of hepatitis A (HBA) in all capital cities showing the shift pattern from high to intermediated/ low endemicity. Differences in age trends of infection were detected among settings. This multilevel model allowed for quantification of contextual predictors of hepatitis A infection in urban areas. Background: Describe the epidemiological and clinical characteristics in the pediatric patients with Acute Liver Failure that were attended in the period between 1998 and 2009 in the different health institutions in Colombia.
Methods: A transversal study based on the revision of clinical histories and questionnaires carried out in 10 health institutions in 5 Colombian cities; including 2 Centers specialized in Transplants to evaluate the cases of Fulminant Hepatic Failure in patients under the age of 18 years of age presented between January 1998 and November 2009. FHF was defined as: 1). The elevation of AST and ALT aminotransferases and/or the elevation of conjugated bilirubin. 2). The absence of known chronic hepatic disease. 3). INR > or equal to 1.5 or PT > or equal to 15 seconds after the administration of vitamin K, if the patient presents encephalopathy or 4). An INR > or equal to 2.0 or TP > or equal to 20 seconds after the administration of vitamin K if encephalopathy is not presented. 5.) The degree of encephalopathy was stratified according to age and according to its classification.
Results: 47 clinical histories were revised and 46 subjects were included. The average age was 5.8 years of age (4 months of age -16 years of age); of which 58.6% corresponded to the female gender; 28.35% (13/46) coming from rural areas. Jaundice was found in 100% of the subjects upon entry and encephalopathy in 76% (35/46). Liver failure was mortal in 32.6% (15/46), with the average age being 6, 5 years of age. Infection as a result of the Hepatitis A Virus was one of the first causes of FHF with 32.6% (15/46) as well as Indeterminate Hepatitis (32.6%) and 15.2% caused by a toxic reaction to the medications. The greatest proportion of deaths is associated to Indeterminate Hepatitis due to the forcefulness of the disease and the limited elements to understand its etiology. 76.6% of the transplant candidates obtained a successful transplant (67%); retransplant was carried out in 2 subjects, one died and the other managed to survive.
Conclusion: Acute Liver Failure is a frequent pathology among the pediatric ages in Colombia and is caused by the Hepatitis A Virus in up to 32.6% of the cases. A high percentage of patients need liver transplantation and in some cases have fatal consequences. Many of these cases are preventable with vaccination. Methods: From June 2007 to december 2008 a seroprevalence study was conducted in 6 Amazonian indigenous populations: Shispibo-Konibo, Ashaninka, Kandozi, Shapra, Chayahuita, Matsigenka. Objective: to determine the magnitude of Hepatitis B infection, and associated factors. Blood samples and written surveys were obtained. Informed consent was obtained from National, Regional and local Community leaders and participants. For Hepatitis B testing, HBsAg and Anti-HBc elisa tests were performed.
Results: 1274 pregnant women and 721 male couples were surveyed. Anti-HBc positive results: 522 women (42.06% [95%CI: 39.30% -44.87%]) and 377 males (54.09% [IC95%CI: 50.31%-57.84%]). HBsAg were positive for 11/393 Anti-HBc positive women (2.80% [IC95%: 1.41% -4.95%]), and 15/312 Anti-HBc positive males (4.81% [IC95%: 2.72%-7.81%]).
Anti-HBc positivity in women was associated to:
